TWD
MED icon

True Wealth Design’s Medifast MED Stock Holding History

True Wealth Design’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$955 Buy
90
+43
+91% +$496 ﹤0.01% 1993
2026
Q1 		$479 Buy
47
+17
+57% +$183 ﹤0.01% 2072
2025
Q4 		$321 Sell
30
-130
-81% -$1.56K ﹤0.01% 2098
2025
Q3 		$2.19K Buy
160
+111
+227% +$1.55K ﹤0.01% 1421
2025
Q2 		$689 Buy
49
+9
+23% +$118 ﹤0.01% 1610
2025
Q1 		$540 Sell
40
-75
-65% -$1.13K ﹤0.01% 1516
2024
Q4 		$2.03K Sell
115
-168
-59% -$3.12K ﹤0.01% 732
2024
Q3 		$5.42K Buy
+283
New +$5.45K ﹤0.01% 535

Other funds holding MED

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
SCP
Steamboat Capital Partners Rye, New York $468M AUM 80.81% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

True Wealth Design's MED Position: Q2 2026 in Review

True Wealth Design increased its Medifast (MED) stake by 91% in Q2 2026, buying an estimated $496 and bringing the position to 90 shares worth $955. The position accounts for ﹤0.01% of the portfolio, ranked #1993.

True Wealth Design first reported a position in MED in Q3 2024 and has held it in 8 quarters since. The position peaked at $5.42K in Q3 2024. 113 funds tracked by Wall St. Rank hold MED as of Q2 2026.

  • True Wealth Design held 90 shares of Medifast worth $955 as of Q2 2026.
  • True Wealth Design bought 43 Medifast shares in Q2 2026, an estimated $496.
  • Medifast made up ﹤0.01% of True Wealth Design's portfolio in Q2 2026, its #1993 holding.
  • True Wealth Design first reported a position in Medifast in Q3 2024 and has held it in 8 quarters since.
  • True Wealth Design's Medifast position peaked at $5.42K in Q3 2024.
  • 113 funds tracked by Wall St. Rank held Medifast as of Q2 2026.

Based on True Wealth Design's 13F filing for Q2 2026, filed 16 Jul 2026.